S V Kane

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint Systematic review: adherence issues in the treatment of ulcerative colitis
    S V Kane
    Section of Gastroenterology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    Aliment Pharmacol Ther 23:577-85. 2006
  2. ncbi request reprint Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission
    Sunanda V Kane
    University of Chicago, Chicago IL 60637, USA
    J Clin Gastroenterol 39:32-5. 2005
  3. ncbi request reprint Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Inflamm Bowel Dis 10:652-4. 2004
  4. ncbi request reprint Inflammatory bowel disease in pregnancy
    Sunanda Kane
    Division of Gastroenterology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
    Gastroenterol Clin North Am 32:323-40. 2003
  5. ncbi request reprint Adherence rates with infliximab therapy in Crohn's disease
    S Kane
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 24:1099-103. 2006
  6. ncbi request reprint Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Am J Med 114:39-43. 2003
  7. ncbi request reprint The effectiveness of budesonide therapy for Crohn's disease
    S V Kane
    Section of Digestive Deseases, University of Chicago School of Medicine, Chicago, Ill 60637, USA
    Aliment Pharmacol Ther 16:1509-17. 2002
  8. ncbi request reprint Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    J Clin Gastroenterol 35:149-50. 2002
  9. ncbi request reprint Novel therapies in the treatment of ulcerative colitis
    S V Kane
    Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago IL 60637, USA
    Expert Opin Investig Drugs 10:1223-9. 2001
  10. ncbi request reprint Gender issues in inflammatory bowel disease
    Sunanda Kane
    Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
    Womens Health (Lond Engl) 1:401-7. 2005

Detail Information

Publications34

  1. ncbi request reprint Systematic review: adherence issues in the treatment of ulcerative colitis
    S V Kane
    Section of Gastroenterology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    Aliment Pharmacol Ther 23:577-85. 2006
    ..It is a combination of understanding patient behaviour, recognizing signs of non-adherent behaviour and utilizing management strategies to change behaviour that will improve patient outcomes...
  2. ncbi request reprint Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission
    Sunanda V Kane
    University of Chicago, Chicago IL 60637, USA
    J Clin Gastroenterol 39:32-5. 2005
    ..To study the association between tobacco exposure and postoperative clinical recurrence in Crohn's disease patients and quantify the time to clinical relapse following surgical resection...
  3. ncbi request reprint Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Inflamm Bowel Dis 10:652-4. 2004
    ..We herein report a patient who developed acute sinusoidal obstruction syndrome after 14 months of successful thioguanine treatment. This is the first report of such a complication in an adult treated with 6-TG for active Crohn's disease...
  4. ncbi request reprint Inflammatory bowel disease in pregnancy
    Sunanda Kane
    Division of Gastroenterology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
    Gastroenterol Clin North Am 32:323-40. 2003
    ..Most medications for IBD are safe during pregnancy and breastfeeding, with notable exceptions. Active disease is usually more deleterious than maintaining medical therapy...
  5. ncbi request reprint Adherence rates with infliximab therapy in Crohn's disease
    S Kane
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 24:1099-103. 2006
    ..Inflammatory bowel disease is associated with non-adherence to treatment with oral medications...
  6. ncbi request reprint Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Am J Med 114:39-43. 2003
    ..We conducted a prospective study to determine the effects of nonadherence with mesalamine among patients with quiescent ulcerative colitis...
  7. ncbi request reprint The effectiveness of budesonide therapy for Crohn's disease
    S V Kane
    Section of Digestive Deseases, University of Chicago School of Medicine, Chicago, Ill 60637, USA
    Aliment Pharmacol Ther 16:1509-17. 2002
    ..Trials had to report on the effectiveness of treatment (defined as decreasing or maintaining Crohn's Disease Activity Index, CDAI, scores < or = 150) or adverse events...
  8. ncbi request reprint Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    J Clin Gastroenterol 35:149-50. 2002
    ..Thalidomide appears to be a safe and effective alternative for short-term healing in patients who develop infliximab-induced delayed hypersensitivity reaction and may be an alternative strategy for those at risk...
  9. ncbi request reprint Novel therapies in the treatment of ulcerative colitis
    S V Kane
    Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago IL 60637, USA
    Expert Opin Investig Drugs 10:1223-9. 2001
    ..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
  10. ncbi request reprint Gender issues in inflammatory bowel disease
    Sunanda Kane
    Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
    Womens Health (Lond Engl) 1:401-7. 2005
    ..Healthcare providers, regardless of their primary focus, should be aware of these differences and be familiar with general information specific to women...
  11. ncbi request reprint Caring for women with inflammatory bowel disease
    S Kane
    Section of Gastroenterology, University of Chicago, 5841 S Maryland Ave, MC 4076, Chicago, IL 60637, USA
    J Gend Specif Med 4:54-9. 2001
    ..Health care providers, regardless of their primary focus, should be aware of these differences and should be familiar with certain general information on gender-specific issues, reviewed in this article...
  12. ncbi request reprint A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis
    Sunanda Kane
    Departments of Medicine and Health Studies, University of Chicago and Illinois Masonic Hospital, Chicago, Illinois 60637, USA
    Clin Gastroenterol Hepatol 1:170-3. 2003
    ..This study was conducted to assess, in a small sample, the short-term outcomes of once-daily mesalamine versus conventional dosing in maintaining quiescent ulcerative colitis (UC) and to assess adherence rates with both regimens...
  13. ncbi request reprint Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
    ..Inhibition of tumor necrosis factor is a proposed mechanism for the anti-inflammatory properties of thalidomide. We performed an open-label trial of thalidomide in refractory Crohn's disease...
  14. doi request reprint Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
    P D R Higgins
    Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
    Aliment Pharmacol Ther 29:247-57. 2009
    ..Ulcerative colitis (UC) can be maintained in remission with 5-aminosalicylic acid (5-ASA) medications, but frequent non-adherence by patients who are feeling well has been associated with more frequent flares of colitis...
  15. ncbi request reprint Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
    S V Kane
    Department of Medicine, University of Chicago, Illinois, USA
    Am J Gastroenterol 96:2929-33. 2001
    ..46 [0.39-0.57]). CONCLUSION: Nonadherence is associated with multiple concomitant medications, male gender, and single status. These patient characteristics may be helpful in targeting those patients at higher risk for nonadherence...
  16. doi request reprint Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience
    S V Kane
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:2203-8. 2012
    ..Natalizumab, a monoclonal antibody to alpha-4 integrin approved for CD, has demonstrated efficacy in randomized clinical trials. We describe our experience with natalizumab in clinical practice at Mayo Clinic Rochester...
  17. ncbi request reprint Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
    U Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, CA 94115, USA
    Aliment Pharmacol Ther 21:733-8. 2005
    ..To study the effects of infliximab on pregnancy and foetal outcome...
  18. doi request reprint Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes
    Deepa Reddy
    Division of Gastroenterology, Mount Sinai Medical Center, One Gustave Levy Place, New York, New York, USA
    Am J Gastroenterol 103:1203-9. 2008
    ....
  19. ncbi request reprint The challenge of compliance and persistence: focus on ulcerative colitis
    Sunanda V Kane
    Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, 200 First Street, SW, 19th Floor, Rochester, MN 55905, USA
    J Manag Care Pharm 14:s2-12; quiz s13-5. 2008
    ..An estimated 20% to 50% of patients with ulcerative colitis (UC) do not take their medications as prescribed, resulting in higher disease-recurrence rates and potentially higher health care costs...
  20. doi request reprint Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease
    Sunanda V Kane
    Mayo Clinic, Rochester, Minnesota and University of Chicago, Chicago, Illinois, USA
    Am J Gastroenterol 103:1193-6. 2008
    ..The nature of inflammatory bowel disease (IBD) following menopause has not been previously studied. The aim of this study was to characterize the effect of menopause on disease activity and identify possible modifiers of disease activity...
  21. ncbi request reprint Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)
    Themistocles Dassopoulos
    Johns Hopkins University Meyerhoff Inflammatory Bowel Disease Center, Baltimore MD, USA
    Inflamm Bowel Dis 13:975-83. 2007
    ..Our aim was to determine the reliability and validity of these phenotypic assessments...
  22. ncbi request reprint The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review
    Sunanda V Kane
    University of Chicago, Chicago, Illinois, USA
    Rev Gastroenterol Disord 3:210-8. 2003
    ..Five-ASA products appear to be as effective as sulfasalazine, but available data do not suggest a difference in efficacy between any of the 5-ASA preparations...
  23. ncbi request reprint Factitious diarrhea masquerading as refractory celiac disease
    Rajesh N Keswani
    Section of Gastroenterology, University of Chicago Hospitals, and Department of Internal Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    South Med J 99:293-5. 2006
    ..This case highlights the importance of considering factitious diarrhea in all patients admitted for refractory diarrhea, even those with documented underlying conditions...
  24. ncbi request reprint Novel therapies in the treatment of ulcerative colitis
    Jeffrey A Tuvlin
    Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago, IL 60637, USA
    Expert Opin Investig Drugs 12:483-90. 2003
    ..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
  25. ncbi request reprint Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts
    Gary R Lichtenstein
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Inflamm Bowel Dis 10:S11-21. 2004
  26. ncbi request reprint Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease
    Gary R Lichtenstein
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Inflamm Bowel Dis 10:S2-10. 2004
    ..Here we also evaluate the current preferable treatment practices, based on scientifically valid research and collective clinical experience, for the management of mild to moderate Crohn's disease...
  27. ncbi request reprint Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes
    Steven R Brant
    The Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Dept of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, U S A
    Inflamm Bowel Dis 9:281-9. 2003
    ..Multiple factors, particularly IBD family history, tobacco use, age at diagnosis and recently, NOD2 mutant genotypes may influence Crohn's disease (CD) heterogeneity...
  28. doi request reprint Disease perceptions among people with Crohn's disease
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 14:1097-101. 2008
    ..We sought to characterize CD patient perceptions of both overall disease course and current symptomatology based on an objective symptom scale and to explore the relationship between perceptions and current symptoms...
  29. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
    Sunanda V Kane
    University of Chicago, Chicago, Illinois 60637, USA
    Am J Gastroenterol 98:1309-14. 2003
    ..The aim of this study was to determine the sensitivity and specificity of fecal lactoferrin concentrations for inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) versus healthy controls...
  30. pmc IBD and Pregnancy
    Audrey H Calderwood
    Department of Medicine, University of Chicago, Chicago, Illinois, USA
    MedGenMed 6:14. 2004
  31. ncbi request reprint Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease
    Stephanie A Blair
    Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
    Lab Invest 86:191-201. 2006
    ..Therefore, these data show that MLCK expression and enzymatic activity are increased in IBD. Moreover, the correlation with disease activity suggests that MLCK upregulation may contribute to barrier dysfunction and IBD pathogenesis...
  32. ncbi request reprint Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease
    Mark S Silverberg
    Department of Medicine, Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, Canada
    Eur J Hum Genet 15:328-35. 2007
    ....
  33. ncbi request reprint Crohn's disease involving the gallbladder. case report and review of the literature
    Carlos A Rettally
    Am J Gastroenterol 98:509-11. 2003
  34. ncbi request reprint Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort
    Geoffrey C Nguyen
    Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Gastroenterol 101:1012-23. 2006
    ..This study was undertaken to characterize racial differences in disease phenotype in a predominantly adult population...